RxDestruct Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $2.45M
Latest Deal Amount
  • Investors
  • 5

RxDestruct General Information

Description

Developer of a waste management system designed to help hospitals and nursing homes to dispose of their pharmaceutical waste safely and conveniently. The company's product helps in neutralizing the active compounds in unused medications so they can be disposed of easily without polluting water supplies, enabling hospitals to ensure pharmaceutical waste stays out of the environment and does not contribute to the current opioid epidemic sweeping the country.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Environmental Services (B2B)
Other Industries
Electrical Equipment
Primary Office
  • 106 Capri Street
  • Sugar Land, TX 77478
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RxDestruct Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 03-Jun-2020 $2.45M 00.000 00.000 Completed Generating Revenue
3. Angel (individual) 24-Oct-2013 00000 Completed Startup
2. Angel (individual) 14-Nov-2011 $342K $342K Completed Startup
1. Accelerator/Incubator Completed Startup
To view RxDestruct’s complete valuation and funding history, request access »

RxDestruct Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00 00 00 00 00.000
To view RxDestruct’s complete cap table history, request access »

RxDestruct Patents

RxDestruct Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210047210-A1 Flow apparatus for treating pharmaceutical waste Pending 13-Aug-2019 0000000000
US-11053145-B2 Apparatus for treating pharmaceutical waste Active 19-Dec-2012 000000000 00
US-20180346359-A1 Apparatus for treating pharmaceutical waste Granted 19-Dec-2012 000000000
CA-2895214-A1 Apparatus for treating pharmaceutical waste Pending 19-Dec-2012 000000000
US-10046993-B2 Apparatus for treating pharmaceutical waste Active 19-Dec-2012 C02F1/722 0
To view RxDestruct’s complete patent history, request access »

RxDestruct Executive Team (3)

Name Title Board Seat Contact Info
Mark Macdonell Chief Executive Officer & Board Member
Thomas Stern Co-Founder & Executive Vice President of Sales
You’re viewing 2 of 3 executive team members. Get the full list »

RxDestruct Board Members (6)

Name Representing Role Since
Chris Cuzalina Self Board Member & Advisor 000 0000
Chris Quinn RxDestruct Board Member 000 0000
Mark Macdonell RxDestruct Chief Executive Officer & Board Member 000 0000
Michael Sanborn RxDestruct Board Member 000 0000
Scott Kosch RxDestruct Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

RxDestruct Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RxDestruct Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cascata Capital Management Growth/Expansion Minority 000 0000 000000 0
i2E Venture Capital Minority 000 0000 000000 0
SeedStep Angels Angel Group Minority 000 0000 000000 0
Scott Kosch Angel (individual) Minority 000 0000 000000 0
Insight Accelerator Labs Accelerator/Incubator Minority 000 0000 000000 0
To view RxDestruct’s complete investors history, request access »